Page 4 - Biotechnology Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Company Profile Today - Breaking & Trending Today

agilon health (NYSE:AGL) and Curative Biotechnology (OTCMKTS:CUBT) Head to Head Contrast

Agilon health (NYSE:AGL – Get Rating) and Curative Biotechnology (OTCMKTS:CUBT – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends. Institutional & Insider Ownership 96.2% of agilon health shares are […] ....

United States , Boca Raton , Company Profile Get Rating , Curative Biotechnology Company Profile Get Rating , Agilon Health Topco Inc , Curative Biotechnology Inc , Atlantic Biotherapeutics Inc , Get Rating , Curative Biotechnology , Company Profile , Agilon Health Topco , Biotechnology Company Profile , Agilon Health , Nyse Agl , Stock Comparison , Stock Analysis ,

Vir Biotechnology (NASDAQ:VIR) Upgraded to Hold at Zacks Investment Research

Vir Biotechnology (NASDAQ:VIR – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The […] ....

United States , San Francisco , Annm Hanly , Robertw Baird , Vickil Sato , Vir Biotechnology Inc , Asset Management Inc , Vir Biotechnology Company Profile Get Rating , Securities Exchange Commission , Zacks Investment Research , Needham Company , Profund Advisors , Asset Management Americas Inc , Macquarie Group Ltd , Vir Biotechnology , Get Rating , Director Vicki , Exchange Commission , State Retirement System , Management Inc , Management Americas , Macquarie Group , Biotechnology Company Profile , Nasdaq Vir ,

Puma Biotechnology, Inc. (NASDAQ:PBYI) Given Average Rating of "Hold" by Analysts

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Rating) has earned an average recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The […] ....

United States , Principal Financial Group Inc , Zacks Investment Research , Invesco Ltd , Puma Biotechnology Inc , Wells Fargo Company , Puma Biotechnology Company Profile Get Rating , Puma Biotechnology , Get Rating , Investment Research , Financial Group , Wells Fargo , Biotechnology Company Profile , Nasdaq Pbyi ,

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Recommendation of "Hold" from Brokerages

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) has received an average rating of “Hold” from the eight ratings firms that are presently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokers that […] ....

United States , Robertw Baird , Vickil Sato , Vir Biotechnology Inc , Asset Management Inc , Vir Biotechnology Company Profile Get Rating , Securities Exchange Commission , Zacks Investment Research , Needham Company , Profund Advisors , Asset Management Americas Inc , Macquarie Group Ltd , Vir Biotechnology , Get Rating , Investment Research , Phillip Pang , Exchange Commission , Director Vicki , State Retirement System , Management Inc , Management Americas , Macquarie Group , Biotechnology Company Profile , Nasdaq Vir ,

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up to $8.68

Sana Biotechnology, Inc. (NASDAQ:SANA – Get Rating) gapped up prior to trading on Tuesday . The stock had previously closed at $8.68, but opened at $9.03. Sana Biotechnology shares last traded at $9.15, with a volume of 2,845 shares trading hands. Separately, Zacks Investment Research downgraded shares of Sana Biotechnology from a “hold” rating to […] ....

Patricky Yang , Allspring Global Investments Holdings , Securities Exchange Commission , Sana Biotechnology Inc , Zacks Investment Research , Sana Biotechnology Company Profile , Deutsche Bank , Victory Capital Management Inc , Royal Bank , Sana Biotechnology , Get Rating , Director Patrick , Exchange Commission , Capital Management , Biotechnology Company Profile , Nasdaq Sana ,